Cabot Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBT research report →
About the company
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
- CEO
- Sean D. Keohane
- IPO
- 1980
- Employees
- 4,073
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $4.46B
- P/E
- 16.11
- P/S
- 1.25
- P/B
- 2.86
- EV/EBITDA
- 7.29
- Div Yield
- 2.11%
- Gross Margin
- 24.95%
- Op Margin
- 15.94%
- Net Margin
- 7.97%
- ROE
- 18.29%
- ROIC
- 11.11%
- Revenue
- $3.71B · -7.04%
- Net Income
- $331.00M · -12.89%
- EPS
- $6.07 · -10.60%
- Op Income
- $621.00M
- FCF YoY
- -13.30%
- 52W High
- $94.53
- 52W Low
- $58.33
- 50D MA
- $83.88
- 200D MA
- $73.87
- Beta
- 0.82
- Avg Volume
- 495.94K
Get TickerSpark's AI analysis on CBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Nathoo Raffiq | other | 261.506 |
| Jun 30, 26 | Keohane Sean D | other | 83.682 |
| Jun 12, 26 | Dumont Lisa M | other | 3.982 |
| Jun 12, 26 | DELGROSSO DOUGLAS G | other | 27.694 |
| Jun 12, 26 | Kalita Karen A | other | 28.47 |
| Jun 12, 26 | Nathoo Raffiq | other | 8.667 |
| Jun 12, 26 | McLaughlin Erica | other | 55.232 |
| Jun 12, 26 | Keohane Sean D | other | 256.014 |
| Jun 12, 26 | Masterson William F III | other | 2.824 |
| Mar 31, 26 | Nathoo Raffiq | other | 315.363 |
Our CBT coverage
Recent articles, reports, and earnings notes.
No research on CBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBT report →Similar companies
Peers in the same neighborhood.